|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
378,184 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-12-03 |
4 |
B |
$1.44 |
$577 |
D/D |
401 |
29,422 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-04-29 |
4 |
A |
$51.26 |
$21,223 |
D/D |
414 |
395,635 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-07-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
425 |
247,533 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-09-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
430 |
226,494 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
450 |
327,070 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-06 |
4 |
AB |
$8.00 |
$4,000 |
D/D |
500 |
6,500 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-12 |
4/A |
AB |
$7.00 |
$3,500 |
D/D |
500 |
7,000 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-12 |
4 |
AB |
$7.00 |
$3,500 |
D/D |
500 |
6,500 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-07 |
4 |
OE |
$6.46 |
$3,230 |
D/D |
500 |
9,667 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
OE |
$9.86 |
$4,930 |
I/I |
500 |
43,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-04-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
228,254 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-07-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
228,754 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
377,684 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-04-28 |
4 |
AB |
$124.26 |
$62,130 |
D/D |
500 |
3,677 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-05-15 |
4 |
AB |
$115.00 |
$57,500 |
D/D |
500 |
4,177 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-05-31 |
4 |
AB |
$131.80 |
$65,900 |
D/D |
500 |
4,677 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-31 |
4 |
AB |
$6.92 |
$3,584 |
D/D |
518 |
7,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
540 |
181,501 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-06 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
9,167 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-11 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
10,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-14 |
4/A |
GD |
$0.00 |
$0 |
I/I |
600 |
182,201 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-12-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
630 |
180,261 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-08 |
4 |
OE |
$6.46 |
$4,199 |
D/D |
650 |
10,317 |
0 |
- |
|
850 Records found
|
|
Page 3 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|